Keeping Current CME cover art

All Episodes

Keeping Current CME — 764 episodes

#
Title
1

Managing MASH in the Modern Era – Episode 3: Metabolic Disease and MASH: What the Endocrinologist Needs to Know

2

Reading the Signal: What Repeated Oral Steroid Use Tells Us in Chronic Rhinosinusitis With Nasal Polyps

3

Keeping Current With COVID-19 Prevention: Expert Insights on Post-Exposure Prophylaxis

4

Timing Matters: Optimizing Biologic Escalation in Moderate to Severe Asthma

5

Current Concepts in the Treatment of MASH

6

The Phosphate Binder Pivot: Navigating Patient Conversations for Novel Hyperphosphatemia Interventions

7

When Steroids Signal Risk: Rethinking COPD Exacerbation Management

8

The Nurse Practitioner as the Medical Home for the Patient With Rett Syndrome

9

Right Care, Right Time: Clinical Pathways for Identifying and Referring Moderate to Severe Asthma

10

Inside the Edit: Lessons From the Field and Emerging Implications for HAE

11

The Chronic Kidney Disease Checkpoint: Keeping Current in Anemia Care for Dialysis-Dependent Patients

12

The Retina Futures Forum: Focus on RVO

13

Interrupting the Pattern: Reducing Steroid Dependence in Moderate to Severe Asthma Through Biologic-Driven Care

14

Breaking Boundaries: Exploring the Latest Advances in Lupus

15

Dravet Syndrome: Where Do Current Therapies Miss the Mark?

16

The Reality of Care for HER2-Mutated Advanced NSCLC: Closing Community Gaps

17

The Intensity Equation: Aligning Multiple Myeloma Combination Strategies With Current Evidence

18

Beyond the Flare: Rethinking Steroid Use and Disease Trajectory in Pediatric Asthma

19

Elevating CLL Care: Integrating Evidence, Guidelines, and the Patient Perspective

20

Optimizing Breast MRI Surveillance in High-Risk Patients: Strategies for Repeat Imaging Excellence

21

Translating Emerging Evidence in IgA Nephropathy: Proteinuria and eGFR as Biomarkers of Disease Progression

22

Alzheimer's Disease Precision Diagnostics: A 3-Part Live Master Class. Part 1: Amyloid Positron Emission Tomography

23

The Triple Monoamine Interplay: What's New in ADHD Treatment

24

Redefining the Patient Journey: The Promise and Practice in NTRK Fusion–Positive Cancers

25

Advancing Corticosteroid Stewardship Across Airway Diseases: When Steroids Signal Risk

26

Protecting the Heart and Kidneys: Primary Care Strategies for Improving Cardio-Kidney-Metabolic Health

27

Helping Patients Implement a Plan for Nicotine Cessation

28

Diagnosing and Managing Obesity-Linked Liver Disease: A Multidisciplinary Masterclass

29

Ask the Experts: Best Practices in Using AID to Simplify Life or Reduce Burden in People Living With T2D

30

Front Line in T2D: Advancing Care With Basal Insulin Excellence

31

Evidence-Based Initiatives for Nicotine Use Prevention

32

Updates on Anti-Seizure Medications for the Management of Lennox-Gastaut Syndrome

33

Pharmacological and Combination Interventions for Nicotine Cessation

34

Next-Generation Gadolinium-Based Contrast Agents: Advancing MRI

35

New Frontiers in IgA Nephropathy: Understanding the Role of B-Cell Modulation

36

Case-Based Discussion on Linking Cognitive Testing With Biomarker Testing in Alzheimer's Disease

37

The Retina Futures Forum: Focus on Wet AMD

38

The New Era of mHSPC Treatment: Evaluating Emerging Doublet and Triplet Combinations

39

The Health Risks of Nicotine Use: A Focus on At-Risk Populations

40

Best Practices in Clinician-Patient Shared Decision-Making for Depression Treatment

41

CETP Inhibition: What We've Learned and What's Next: Quickfire Countdown

42

In the Clinic: Managing Emotional Dysregulation and Executive Dysfunction in an Adult With ADHD

43

From Data to the Dialysis Unit: Integrating Novel Therapies for Hyperphosphatemia in Dialysis-Dependent CKD

44

Hot Off the Press: New Evidence for Emerging Therapies in Nondiabetic CKD Management

45

Ask the Experts: Best Practices in Using AID to Solve Titration Challenges in People Living With T2D

46

Marketing Influence Related to Nicotine-Containing Products

47

Behavioral and Non-Pharmacologic Interventions for Nicotine Cessation

48

Updates on Metabolic Dysfunction-Associated Steatohepatitis Treatment

49

Unlocking the Enigma of Low Back Pain: Zeroing In on Effective Treatment Options

50

Managing MASH in the Modern Era - Episode 2: Managing MASH: A Guide for GI Specialists

51

Chronic Lymphocytic Leukemia: Data-Driven Updates in First-Line and R/R Disease

52

Personalizing Cardiovascular Prevention: From Methods to Meaning

53

Navigating Next Steps in CLL: A Collaborative Dialogue

54

Navigating the Psychosocial Impact of Dermatologic Disease: The Patient Journey

55

Advancing Care in Acromegaly: Expert Insights on Optimizing Current Diagnostic and Care Strategies

56

The Patient Voice in MDD: Why and When to Augment Therapy

57

Managing Erosive Esophagitis: When PPIs Are Insufficient

58

CKD and the Heart: An Expert Digest From WCN 2026

59

Advocating for Nicotine-Free Youth and a Healthy Community

60

Breaking News in IBS-C: Real-World Expert Insights, Patient Voices, and Challenging Cases

61

Ready for Launch in Gastroesophageal Adenocarcinoma: Anti-HER2 Innovation in First-Line Management

62

Orexin and Hyperarousal in MDD: A Rapid-Fire Review

63

Beyond Sedation: Reexamining Insomnia as a Core Symptom of MDD: The Role of Novel Orexin-Based Strategies

64

Beyond the Total Score: Screening and Diagnosing the Challenging Symptoms of Depression

65

Expert Panel Decision Framework: Progressive Strategies for Managing HER2-Mutated Advanced NSCLC

66

Imaging in Action: Patient Cases

67

Rett Syndrome Year In Review: What We Learned in 2025 and Beyond

68

Managing MASH in the Modern Era - Episode 1: Identifying MASH for GI Specialists

69

Interprofessional Approach to Adverse Event Care for the Patient With High-Risk Hormone Receptor-Positive/HER2-Negative Early Breast Cancer

70

Addressing the Intersection Between Heart Failure and Kidney Disease: Have We Reached a Consensus?

71

Connect With Your Patient Living With Depression: Are They a Good Candidate for an Augmentation Treatment?

72

Beyond Lifestyle: Managing Cardiovascular Risk With Medications

73

Sharing the Decision of Treatment Planning in High-Risk HR+/HER2- Early Breast Cancer

74

Personalizing Risk Assessment to Enhance Cardiovascular Prevention: Quickfire Countdown With Imaging Experts

75

Noninvasive Assessment of MASH Fibrosis

76

Rapid Fire: Your Questions on Obesity and Liver Disease Answered

77

Best Practices in Patient Communication When Introducing Biosimilars Into Multiple Sclerosis Care

78

Ask the Experts: Best Practices in Using AID to Achieve Outcomes Faster and Safely in People Living With T2D

79

Carotid Ultrasound: Seeing Vascular Age

80

The Practical Community Colorectal Cancer Clinic: Aligning Biomarker Analysis to Treatment Selection

81

Empowering Frontline Care in IBS-C: Moving Beyond OTC Therapies

82

The Right Fit: Personalizing COPD Device Selection Across the Patient Journey

83

When Monotherapy Fails in Depression: An Evidence-Based Update

84

From Symptoms to Success: Real-World Cases in Patient-Centered IBS-C Care

85

Multidisciplinary Management of Metabolic Dysfunction-Associated Steatohepatitis

86

Advancing Care in HER2-Mutated NSCLC: Evidence, Diagnostics, and Future Directions

87

The Mechanisms Behind Rapid-Acting Treatments for Major Depressive Disorder

88

Cracking the Code With Coronary Artery Calcium (CAC)

89

Cracking the Code: Optimizing Outcomes in All Patients With High-Risk HR+/HER2-Negative Early Breast Cancer

90

Breaking the OTC Cycle: Optimizing Prescription Therapy for IBS-C in Everyday Practice

91

Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer

92

Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence

93

Beyond the Headlines: A Critical Look at MRA Evidence in HFpEF

94

Up Front Antibody-Drug Conjugates: Shifting the Paradigm in Metastatic Triple-Negative Breast Cancer Treatment

95

Biosimilars: What Primary Care Needs to Know About Biosimilars in Practice

96

Enhancing Clinical Understanding of Oral SERD-Based Therapies for Patients With ER-Positive/HER2-Negative MBC

97

Maximizing Therapeutic Efficacy Prior to Epilepsy Surgery: Considerations for the Selection of Antiseizure Medications

98

Expanding the Actionability of Crucial Biomarkers in Your Community-Based Colorectal Cancer Clinic

99

Identifying Suboptimally Managed Erosive Esophagitis in Clinical Practice

100

Steps for Personalized and Collaborative Decision-Making in HER2-Mutated NSCLC

101

The Nurse View: Evolution of Anti-HER2 Therapies in Gastroesophageal Adenocarcinoma

102

Progressive Familial Intrahepatic Cholestasis: Case From the Community

103

Rapid Reports in Dravet Syndrome: Synthesizing Pipeline Developments

104

Demystifying Bronchiectasis: Rethinking Standards of Care

105

Breaking Ground in Gastroesophageal Adenocarcinoma: First-Line Anti-HER2 Therapy for Advanced Disease

106

Chronic Lymphocytic Leukemia (CLL): Review of Combination Approaches

107

Quick Talk on ES-SCLC: What Community Clinicians Need to Know Now

108

Best Practices for Integrating Biosimilars Into Clinical Practice: An Interprofessional Perspective

109

CAR T Cells in SLE: A New Frontier in Autoimmunity

110

Case by Case: Managing ES-SCLC in the Real World Through Patient Partnership

111

Utilizing Automated Insulin Delivery to Close Gaps in Type 2 Diabetes Care

112

Empowering Choices in Moderate to Severe Asthma: Partnering With Patients for Optimal Treatment Decisions

113

Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data

114

COPD Device Decisions That Matter: Who Really Benefits From Nebulized Therapy?

115

Game Over: Stop the Ongoing Seizure

116

Genetic Testing for Dravet Syndrome: A Patient–Physician Communication Module

117

Patient-Centered Approaches to Indolent Systemic Mastocytosis: Advancing Care and Reducing Diagnostic Delays

118

Highlights From the Annual Neuro-Oncology Conference: Redefining IDH-Mutant Glioma Management

119

Empowering Nursing Care in Acromegaly: Strategies for Enhanced Diagnosis and Management

120

Navigating Advances in IgA Nephropathy: Key Developments for Therapies Targeting the B-Cell Pathway

121

Precision Oncology in HER2-Mutated NSCLC: Strategies for Today and Tomorrow

122

From Approval to Practice: Expert Approaches to Infusion Site Reactions in Parkinson Treatment

123

Real-Time Insights Into the Diagnosis and Management of ATTR: From Genetic Insight to Therapeutic Innovation

124

Building the Case for Nonsteroidal Topical Atopic Dermatitis Treatments

125

Case Review in Narcolepsy and Idiopathic Hypersomnia: Integrating Treatment Decisions That Prioritize Sleep Quality and Cardiovascular Risk

126

Highlights From the Annual Neuro-Oncology Conference: Integrating IDH Inhibitor Therapy Into Glioma Care

127

Navigating Advances in TRK Fusion-Positive Cancers: A Collaborative Journey From Testing to Therapy

128

Elevating Anemia Care: New Strategies for Dialysis-Dependent Chronic Kidney Disease

129

The Cardio-Kidney-Metabolic Collective: Piecing Multidisciplinary and Patient Insights to Optimize Care

130

Spotlight on Obstructive Sleep Apnea: Focus on HCP-Patient Communication and Shared Decision-Making

131

Collaborative Care in Pediatric Atopic Dermatitis: A Multidisciplinary Approach

132

Advancements in Treatment for Inflammatory Conditions: The Role of Interdisciplinary Coordination in Effective Care Planning

133

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

134

Exploring JAK Inhibitors for Atopic Dermatitis

135

Mastering Oral Therapies in CLL and MCL: Essential Strategies and Insights for Nurses

136

Expert Conversations in Narcolepsy: Improving Sleep Quality While Considering Cardiovascular Comorbidities

137

The Genotype-Phenotype Connection in Dravet Syndrome: Preparing for the Future

138

HER2 Evolution in Gastroesophageal Cancer: New Therapies and Optimized Outcomes

139

Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies

140

Advancing COPD Care Through Precision Medicine and Patient Empowerment

141

The Metabolic Dysfunction-Associated Steatohepatitis Countdown

142

From Screening to Action: Addressing Chronic Kidney Disease to Reduce Cardiovascular Risk

143

The COVID Countdown: The Latest in Safeguarding Protection and Treatment for Vulnerable Populations

144

Cardiovascular Safety and Symptom Management of Narcolepsy and Idiopathic Hypersomnia

145

Narcolepsy and Idiopathic Hypersomnia as 24-Hour Conditions: Prioritizing Sleep Quality

146

Constipation Clash: An IBS-C Challenge

147

Communicating to Enhance Care Through Data and Patient Experience: ER-Positive/HER2-Negative Metastatic Breast Cancer Edition

148

Highlights From San Francisco: The Evolving Role of The Radiation Oncologist in Lower-Grade Glioma Care

149

Mind Matters - Expert Insights on the Importance of Mental Wellness for Patients Living With Inflammatory Arthritic Conditions

150

Expanding Automated Insulin Delivery to Type 2 Diabetes: Where Are We Now?

151

Liver MRI: News From the Front Lines

152

Between the Lines of Depression: Navigating Diagnostic Nuances and Treatment Strategies

153

Elevating the Therapeutic Needs of People With Huntingtons Disease: A Look Into the Future

154

International Voices in Alzheimer's Disease: Regional Perspectives on Diagnosis and Management

155

ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?

156

Breathing New Life Into COPD: Empowering Patients Through Therapy Innovation

157

Clinical Pearls: Navigating Challenges in Anemia of Dialysis-Dependent Chronic Kidney Disease

158

Missed and At-Risk: Rewriting the Cervical Cancer Screening Story

159

Optimizing Cardiovascular-Kidney-Metabolic Care With Interdisciplinary Insights

160

HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: Updates and Insights

161

Debating New IBD Treatments: Ready, Set, Go!

162

Chronic Rhinosinusitis With Nasal Polyps Reimagined: Bridging Surgery and Biologics to Improve Patient Outcomes

163

Endocrine Therapies in ER-Positive/HER2-Negative MBC: Understanding Their Benefits and Limitations to Optimize Treatment Selection

164

The Clock Is Ticking: Optimizing Ongoing Seizure Response

165

Beyond the Inhaled Corticosteroid Plateau: Targeted Strategies for Moderate to Severe Asthma

166

Inflammatory Bowel Disease: Why Mental Health and Wellness Matter

167

Bridging the Gap: Case-Based Exploration of Current and Emerging Therapies in IgA Nephropathy

168

Atopic Dermatitis: It's More Than Skin Deep

169

Top 10 Clinical Pearls: Outlining Optimal Care for Nasopharyngeal Carcinoma

170

Atopic Dermatitis Balancing Act: Exploring the Safety and Efficacy of JAK Inhibitors in Practice

171

Diagnosing Rheumatoid Arthritis Early: Integrating Serologic and Biomarker Tests

172

An Expert Discussion of Key New Data in CLL and MCL: How May It Impact Future Practice?

173

Coming Together in the Community: Discussing Nasopharyngeal Carcinoma Care Strategies

174

Changing the Game in Hepatitis B Care: Breakthroughs and Advances to Optimize Patient Outcomes

175

Navigating the New Era of Heart Failure Treatment: Practical Use of Nonsteroidal Mineralocorticoid Receptor Antagonists

176

Framing the Future of Topical Therapies for Atopic Dermatitis

177

Recognizing and Managing Variant ATTR Amyloidosis: Focus on Early Clues in Black Patients

178

Revolutionizing Postpartum Depression Care: Expert Insights and Patient Perspectives on the Diagnostic Journey and Treatment Approaches

179

Expert Perspectives on the Latest Clinical Trial Updates in HR-Positive, HER2-Negative Early Breast Cancer

180

Considerations for Shared Decision-Making on the Use of Anti-Amyloid Therapies in Clinical Practice

181

Precision Imaging in Cardiac MRI: Late Gadolinium-Enhanced Imaging

182

Beat the Clock: Can We Achieve Faster Control of Acute Seizures?

183

Implementing the Metabolic Dysfunction–Associated Steatohepatitis Care Pathway in Practice

184

Precision Imaging in MRI: Brain Imaging

185

MRI Workup of Ischemic Heart Disease: Insights and Innovations

186

Celebrating Advances and Addressing Inadequacies in Hypercortisolism Management in the Modern Era

187

Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD

188

A How-To Guide to the Use of Anti-Amyloid Therapies: Recommendations for Setting Up Your Practice

189

The Role of Neuroradiology in the Ongoing Safety Monitoring and Care of Patients Receiving an Anti-Amyloid Therapy for Early Alzheimer's Disease

190

Postpartum Depression: An Expert Quickfire Dialogue on Diagnosis

191

Patients' Insights Illuminated: A Rapid-Fire Dive Into CLL and MCL

192

Implementing Comprehensive Genomic Profiling Into Your Oncology Care Plan

193

The Patient With T2D and Early-Stage CKD in Primary Care

194

Empowering Mothers: Early Identification and Treatment of Postpartum Depression

195

Optimizing Outcomes for Thyroid Cancer With NTRK Gene Fusions: Precision Care, Patient Impact

196

Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer: Translating Science Into Clinical Practice

197

Visual Insights: Exploring the Disease-Modifying Effects of Anti-APRIL Treatments for IgA Nephropathy

198

Transforming Gastric and GEJ Cancer Care With Perioperative Immunotherapy: Latest Updates From Chicago

199

Hereditary Angioedema Headlines: Early Intervention Strategies for Managing Attacks and Improving Patient Outcomes

200

Highlights From the Annual Oncology Meeting: Clinical Integration of Therapeutic Innovations in Glioma

201

Med Feud Challenge in Narcolepsy: The Winning Formula for Personalizing Treatment and Prioritizing Safety

202

Case Challenges in Rett Syndrome: Reducing the Time to Genetic Testing, Diagnosis, and Treatment

203

Precision Imaging in Liver MRI

204

Alzheimer's Disease Diagnosis, Response, and the Neuroradiologist and Nuclear Medicine Specialist: Tactics, Strategies, and Best Practices

205

Collaborative Care: Navigating Multidisciplinary Management of CLL and MCL for Optimal Patient Outcomes

206

New Standards in Diffuse Lower-Grade Gliomas: Integrative Management From Surgery to Survivorship

207

Tackling Complex HIV Cases: Navigating Drug-Drug Interactions With Long-Acting Injectables in HIV Care Today

208

The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease

209

A Review of the Scientific Basis of Alzheimer's Disease for Neuroradiologists and Nuclear Medicine Specialists

210

Management of Early Alzheimer's Disease: Merging Clinical Data and Clinical Decision-Making

211

Maximizing Success in HIV Prevention and Treatment: Reframing Drug–Drug Interactions in the Era of Long-Acting Injectables

212

Breaking News: What You're Itching to Know About Primary Biliary Cholangitis and Pruritus

213

How Do I Know If Renal Denervation Is Right for My Hypertension Patient?

214

From Diagnosis to Treatment: Multidisciplinary Pathways for Effective Nasopharyngeal Carcinoma Care

215

Case-Based Insights on Managing Constipation

216

Unlocking Skin Glycation: Bridging Science, Data, and Clinical Impact

217

New and Emerging Adjunctive Treatments for Major Depressive Disorder

218

Unraveling the Perplexities of Mixed Features in Mood Disorders: Expert Insights

219

The RSV Rundown: Expert Reports on Current Insights and Vaccine Recommendations

220

Precision in Practice: Essential Strategies for Genomic Testing in NSCLC

221

Applying Recent Data to Your Everyday Practice in Biliary Tract Cancers

222

Primary Care Strategies for Reducing Cardiovascular and Kidney Risks in Diabetes

223

Informing Alzheimer's Disease Referral: Blood-Based Biomarker Evaluation in Primary Care

224

Enhancing Primary Care Confidence in Managing Obstructive Sleep Apnea in Patients With Comorbidities

225

Community Focus: Addressing Gaps and Elevating Care for Patients With Basal Cell Carcinoma

226

Educating, Empowering, and Engaging: A Focus on HER2-Activating Mutations in NSCLC

227

Navigating the Future: A Clinical Roadmap for Anti-Amyloid Therapies in Alzheimer's Disease

228

Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained

229

Clinical Trials in CLL and MCL: Expert In-Depth Analysis

230

A Multidisciplinary Approach to Identifying and Managing Cortisol Dysfunction

231

Best Practices for the Multidisciplinary Care of Patients With Early-Stage ALK-Positive NSCLC

232

Preeclampsia Biomarker Screening in Every Trimester

233

How Many Lymph Nodes Are Involved in This Patient With HR-Positive, HER2-Negative Early Breast Cancer?

234

Chronic Myeloid Leukemia: A 2025 Update on Novel Targets and Recent Clinical Data

235

Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

236

The Itch Factor: Troublesome Symptoms and Dermatologic Conditions

237

Unlocking the Path to Optimal Severe Asthma Care: Strategies for Success

238

Clinical Cases in HR-Positive, HER2-Negative Early Breast Cancer: Applying the Latest Evidence

239

Exploring the Role of the Psychiatry Professional in the Care of People With PTSD

240

New Paradigms in Hypertrophic Cardiomyopathy Care Gameshow Challenge: Cardiac Myosin Inhibition

241

Advancing Hyperphosphatemia One Dose at a Time

242

Advancing Care in HSCT-TMA: Strategies for Early Recognition and Management

243

ASH 2024 Highlights of Key Lymphoma Data

244

Moving the Needle in ER-Positive/HER2-Negative Metastatic Breast Cancer: Exploring SERD Strategies to Optimize Outcomes

245

Comprehensive and Personalized Approach to Managing mHSPC: Fitting the Right Pieces for Each Patient

246

Posttraumatic Stress Disorder in Primary Care: Understanding Roles and Responsibilities

247

Emerging IgA Nephropathy Advances: Digging Deep in the B-Cell Pathway

248

Unlocking Minds: Navigating the Labyrinth of Cognitive Impairment Associated With Schizophrenia

249

HER2-Positive Biliary Tract Cancer: New Developments and Future Directions

250

Translating Diagnostic Updates in Agitation in Alzheimer's Disease for the Primary Care Practitioner

251

Putting Posttraumatic Stress Disorder Into Perspective for the Practicing Clinician: A Patient Introduction

252

Deconstructing the Diagnostic Journey: Identifying Bipolar Depression

253

Understanding and Managing Schizophrenia in the Digital Therapeutics World: An Interactive Update

254

Unpacking New Data From 2024 Congresses on Transthyretin Amyloid Cardiomyopathy

255

Critical Decision Points in Bloodstream Infection Management: Evolving Approaches With Rapid Diagnostics

256

Innovations and Breakthroughs in Epinephrine Delivery: Optimizing Outcomes With Early Intervention for Anaphylaxis

257

Recognizing Intersecting Symptoms and Their Implications in Mood Disorders

258

Expert Update on Current and Emerging Pharmacotherapies in Patients With Major Depressive Disorder Who Have Inadequate Response

259

Pediatric TRK Fusion-Positive Cancer: Optimizing Care With TRK Inhibitors

260

Differential Diagnosis of Pediatric Cholestatic Liver Diseases

261

Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice

262

Discussing Key Clinical Decisions in Managing Primary Biliary Cholangitis

263

Managing Gastroesophageal Reflux Disease: Who Is in the Waiting Room?

264

New Frontiers in NSCLC: The Promise and Progress of HER2-Directed Therapies

265

Exploring the Pathophysiological Basis of Post-Traumatic Stress Disorder

266

Back to Basics in Agitation Associated With Alzheimer's Disease: Mechanisms and Implications for Treatment

267

Expert Roundtable on the Use of Anti-Amyloid Therapies for the Treatment of Alzheimer's Disease

268

Reflux Is Everywhere: A Primary Care Guide to Managing Gastroesophageal Reflux Disease

269

Medscape Onsite: Riding the Wave of NSCLC Updates From San Diego

270

Updates on Renal Denervation From the 2024 European Society of Cardiology Guidelines on Hypertension

271

Hidden Unmet Needs in Schizophrenia: What Every Healthcare Professional Needs to Know

272

Spotlight on Liver MRI: Diagnosing and Managing Hepatocellular Carcinoma

273

Modeling Guideline-Concordant Therapy Selection in the Adjuvant Setting for Endometrial Cancer

274

Evolution of HER2-Targeted Therapy in Biliary Tract Cancer

275

Spotlight on Liver MRI: Fatty Liver Disease

276

Cognition in Psychiatry and Schizophrenia: All You Need to Know in 15 Minutes

277

Data Highlights in Alzheimer's Disease From the 2024 AAIC Annual Meeting

278

Mastering Multiplex Testing for Diagnosing Pneumonia: From Interpretation to Application

279

Expert Perspectives on the Future of IgA Nephropathy Treatment

280

Breaking Down the Burden of IgA Nephropathy With Clinician and Patient Perspectives

281

Putting Data Into Context for Congenital Adrenal Hyperplasia Treatment Advances

282

Don't Go With Your Gut: Optimizing GI Infection Management With Rapid Diagnostic Panels

283

The Multiple Layers of Major Depressive Disorder Management: Unravelling the Who, When, and How for Antidepressant Modification

284

Exploring Innovations in Lung Cancer Care: Updates From Chicago

285

Key Clinical Characteristics of IgA Nephropathy to Apply in Practice

286

Building Confidence in Care: Strategies to Address Vaccine Hesitancy in Hispanic Communities

287

Navigating Relapsed/Refractory CLL/SLL Together: Where Disease-, Treatment-, and Patient-Centered Care Unite

288

Navigating Patient-Centered Care of CLL and MCL: Empowering Collaboration and Communication

289

Unmasking Cognitive Impairment and Negative Symptoms in Schizophrenia

290

What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies

291

Expert Opinions on Treating Metabolic Dysfunction-Associated Steatohepatitis

292

Connecting With the Experts at ASCO 2024: Clinical Pearls and Data Insights About Anti-HER2 Therapies in Biliary Tract Cancer

293

Life With Cardiac Amyloidosis

294

Quiz Time! Test Your Knowledge on Treatments for Gastroesophageal Reflux Disease

295

What's New in the Treatment of Gastroesophageal Reflux Disease and Erosive Esophagitis: Spring Meeting Updates

296

EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies

297

There Are Multiple Ways to Treat R/R CLL or R/R MCL: What Would the Experts Do?

298

Multiple Sclerosis Biosimilars in the United States: How to Communicate With Your Patient for Successful Implementation

299

To Switch or Not to Switch: Patient Case Discussions on Integrating Biosimilars in Multiple Sclerosis Care

300

Enhancing Equitable HIV Care With Long-Acting Injectable Antiretrovirals: Why It Matters

301

International Expert Recommendations for Timely and Accurate Diagnosis of Alzheimer's Disease in Primary Care

302

Case Study in Managing in MASLD/MASH

303

Renal Denervation for High Blood Pressure: Long-Term Control or Short-Term Bandage?

304

Cardiac Implantable Electronic Device (CIED) Infections: How Well Are Patients Really Doing? Real-Time Gaps and Implications for Evidence-Based Care

305

Beyond Positive Symptoms in Schizophrenia: What Else Should We Be Actively Looking Out For?

306

Improving Outcomes in Schizophrenia in Underserved Communities

307

Hepatitis C Screening and Beyond: Role of the Primary Care Team in Addressing Inequities

308

Evolution of the Care of Patients With Advanced Ovarian Cancer

309

Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?

310

Knowing How and When to Switch Medications in Schizophrenia

311

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

312

Care Pathways for Diagnostic Excellence: Understanding Provider Roles and Responsibilities

313

Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

314

Insights From the Experts on Prescription Digital Therapeutics in Psychiatry

315

Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors

316

Expert Analysis of Hereditary Angioedema Data: Unlocking Practice Implications From AAAAI

317

Obesity in Childhood and Adolescence: The Pediatrician in Charge?

318

Identify and Act, Part 2: What's New in Managing Homozygous Familial Hypercholesterolemia?

319

Navigating the Management of Epidermolysis Bullosa: A Case-Based Discussion on How to Integrate Novel Therapies Into Clinical Practice

320

Primary Biliary Cholangitis: Targeting New Treatment Goals

321

Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer

322

What You Always Wanted to Know About Obesity but Never Dared to Ask: Quick Questions and Rapid Replies

323

Selecting Therapies to Optimize Treatment Success in Schizophrenia

324

Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations

325

Which Endpoints Matter Most in Transthyretin Amyloid Cardiomyopathy Trials? Are We Comparing Apples to Apples?

326

Current Unmet Needs in Schizophrenia: Assessing Gaps in Care

327

Cognitive Impairment and Negative Symptoms in Schizophrenia: Recognizing Hidden Disabilities

328

Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?

329

OncoChallenge in Locally Advanced Head and Neck Cancer: Exploring New Directions

330

Updates on Cardiac Implantable Electronic Device Infections: New Data Driving the Need to Treat and Beat Infection

331

6 Practical Steps to Integrating Long-Acting Injectables for HIV Prevention and Treatment

332

Advances in Topical Treatments for Seborrheic Dermatitis

333

Clinical Debates in Psoriatic Arthritis: Is a JAK Inhibitor Right for This Patient?

334

Evolving Landscape of HR-Positive Metastatic Breast Cancer: A Year in Review

335

The Science of Janus Kinase Inhibitors Across Immunologic Diseases

336

Relapsed/Refractory Multiple Myeloma: A Case-Based Tumor Board

337

Cardiac Amyloidosis: The Red Flags to Consider

338

The Expanding Role of Mutation Testing in Advanced Gastrointestinal Stromal Tumor: From Biology to Therapy Rationale

339

How to Prepare Yourself and Your Practice for Adults With Rare Pediatric-Onset Epilepsies

340

Applying the Evidence: Newer Therapies for Dravet Syndrome and Lennox-Gastaut Syndrome

341

Updates in Breast Cancer From San Antonio 2023: Practice-Changing Data and Clinical Implications

342

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?

343

Multidisciplinary Team Best Practices to Improve Adherence for High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Cases From the Community

344

The Age of Respiratory Syncytial Virus Prevention: Empowering Pharmacists to Optimize Disease Protection in Older Adults

345

Essential Facts About Obesity: Effective and Appropriate Use of Novel Weight-Loss Medications

346

Confronting Obesity in Cardiology Care: A Major Driver of Cardiovascular Risk

347

Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at High Risk of Recurrence

348

Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations

349

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

350

Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice

351

From Symptom to Solution: Best Practices in Syndromic Testing for Improved Patient Outcomes

352

Novel Biologic Therapies for Spondyloarthritis: The Year in Review

353

Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors

354

Personalizing Risk Assessment to Enhance Primary Cardiovascular Prevention: From Methods to Interpretation

355

Nonalcoholic Steatohepatitis: Mission Possible!

356

Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer

357

ROS1-Positive Advanced NSCLC: Sharing Best Practice From the Clinic to Maximize Patient Outcomes

358

What Does It All Mean for Your Practice? Closing Remarks From the Conference Chairs

359

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

360

Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit

361

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate

362

Communication Strategies With Caregivers Following the Diagnosis of Rett Syndrome

363

2023 Rett Syndrome Year in Review: Expert Discussion on What's New

364

Keeping It Current: Latest European Updates in Prostate and Bladder Cancer

365

Strategies for Improving Patient Outcomes in Pediatric-Onset Seizures

366

Immunotherapy in Special Populations With Non-Small Cell Lung Cancer: What Would the Oncologist Do?

367

Navigating the Patient Journey for LA SCCHN: A Look at Treatments for Today and Tomorrow

368

Accessible Fertility Care: Breaking the Silence on Infertility

369

Biologic Treatment Selection for Psoriatic Disease in a Complex Treatment Landscape

370

Hidden in Plain Sight: Anticholinergic Burden in Patients With Overactive Bladder

371

Quickfire Updates From Brisbane: Expert Insights on the Latest Data and Implications for HIV Care

372

Practice Pearls for Managing Opioid-Induced Constipation

373

Cardiac MRI: Case Studies in Improving Patient Outcomes

374

To Know Is Better With Rapid Diagnostic Tests: Optimizing Respiratory Infection Management in Urgent Care

375

Great Debates in Primary Cardiovascular Prevention: Evaluating the Role of Aspirin

376

Improving Heart Failure Prognosis: Electronic Health Record Screening Tools to Detect Iron Deficiency

377

Psychiatry Mid-Year Review: Data Highlights on Antipsychotic Therapies

378

Clinical Consult in Nonalcoholic Steatohepatitis: Managing Intermediate- and High-Risk Patients

379

Clinical Pearls for Syndromic Testing: Closing the Loop on Acute Respiratory Infection Management

380

Expert Quickfire: Perspectives on the Burden and Prevention of Shingles

381

Hot Topics in Schizophrenia: Expert Poster Presentations From 2023 Psychiatry Congresses

382

Best Practices in the Identification and Management of Agitation Due to Alzheimer's Disease

383

Current Guidelines for Osteoarthritis: What Are the Practice Implications for Oral NSAIDs?

384

Taking Control of Fertility With Personalized Insights: Leveling the Fertility Care Continuum

385

The Patient's Journey With Type 1 Diabetes: From Screening to Diagnosis and Management

386

Raising the Bar: Optimizing Outcomes in Spondyloarthritis

387

Immunoglobulin A Nephropathy -- Targeting Gut Mucosal Immunity to Modify the Course of the Disease

388

Expert Insights Into the Biosafety of Oncolytic Immunotherapies and Their Combination With Immune Checkpoint Inhibitors

389

Deciphering Alzheimer's Disease Pathogenesis: From Signaling Pathways to Current Therapeutic Targets

390

A Detective Journey for Nephrologists: Practical Approaches to Differential Diagnosis of Rare Kidney Diseases

391

Ultrafast, Abbreviated, and Conventional Breast MRI: Who and Why?

392

Clinical Consult in Nonalcoholic Steatohepatitis: Are Your Patients at Risk?

393

Clinical Pearls in Diagnostic Stewardship: From Knowledge to Application

394

Nursing and Pharmacy Perspectives: Strategies for Optimizing the Care of Patients With Metastatic Melanoma

395

Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer

396

Multiparametric MRI for Active Surveillance of Prostate Cancer

397

Mechanisms for Delaying/Preventing Type 1 Diabetes Clinical Onset

398

Novel Strategies for Cardiorenal Risk Control in Patients With T2D: Quick Questions, Rapid Replies

399

Congenital Cytomegalovirus Management: What Does the Care Team Look Like?

400

Untangling the Role of Muscarinic Receptors in Psychotic Disorders

401

Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations

402

Socioeconomic Disparities of Cytomegalovirus

403

Facing the Challenge of Multiply Relapsed Myeloma in the Community Setting

404

Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm

405

Clinical Trends in MR Vessel Wall Imaging

406

Merging Established and Emerging Therapeutics in Rett Syndrome: Case Conversations

407

Is Cytomegalovirus a Silent Threat for Parents and Children? Understanding the Burden and Consequences

408

Let's Talk Relapsed/Refractory Chronic Lymphocytic Leukemia: Expert Perspectives on Reversible BTK Inhibitors

409

Wilson Disease: What's on the Horizon?

410

Clinical Updates in Hereditary Breast Cancer: Highlights From Vienna 2023

411

Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines

412

A Roadmap to Elimination: Integrating Hepatitis C Diagnosis and Management Into Everyday Primary Care

413

Practical Management of Early Relapses in the Myeloma Clinic

414

Data Deep Dive: What's New in Biologic Therapies for Psoriatic Arthritis and Axial Spondyloarthritis?

415

Diagnostic Pathways in Agitation Associated With Alzheimer's Disease

416

The Gut-Kidney Axis in IgAN: Can Novel Therapies Change the Disease Paradigm?

417

Diabetes Dialogue Part 1: Pursuing Holistic Treatment Concepts With GLP-1 Receptor Agonists in Primary Care

418

What You Didn't Learn in Medical School About Cannabinoids

419

Staying Alert to Infertility: Key Hormonal Indicators

420

BTK Inhibitors for CLL and MCL: What the Latest Data Mean for Our Patients

421

Optimizing Outcomes for Spondyloarthritis: Focus on Interleukin-23/-17 Inhibitors

422

Depicting LAG3: Exploring a New Target in Metastatic Melanoma

423

Updates on Treating Newly Diagnosed Multiple Myeloma

424

Exploring Data on Emerging Treatments for Primary Biliary Cholangitis

425

Acute Myeloid Leukemia and the Role of FLT3 Inhibitors: Best Practices for the Interprofessional Care Team

426

New Automated Insulin Delivery Recommendations Coming in HOT!

427

Risk-Adapted Management of Multiple Myeloma in the Era of Modern Therapy

428

Intranasal Sprays for Allergy Relief: Clearing the Air

429

Novel Nonsteroidal Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease in Type 2 Diabetes: A Step Change in Treatment?

430

Behavioral Symptoms in Alzheimer's Disease: Getting Into Focus With Agitation

431

Establishing Better Standards of Practice: Maximizing Patient Outcomes With Noninvasive Screening in Nonalcoholic Fatty Liver Disease

432

Best Practices in the Care of Adult Patients With Spinal Muscular Atrophy

433

Novel Antipsychotic Therapies: A Review of Non-D2 Mechanisms and Implications for Care

434

Understanding IgA Nephropathy: Evolving Insights Into Disease State Pathophysiology as a Foundation for Novel Treatment Options

435

From Principles to Practice: Recent Data on Diagnosing Acute Upper Respiratory Tract Infections

436

Acute Kidney Injury After Cardiac Surgery: Expert Insights on Current Understanding

437

An Expert Panel Discussion on the Importance of Cytomegalovirus (CMV) Prevention and Congenital CMV Infection

438

Raising the Bar in Schizophrenia Care

439

Current Perspectives in Mood Disorders

440

Current Challenges in Child and Adolescent Psychiatry

441

Weight Gain and Women With HIV: Evolving Understanding and Optimizing Interventions

442

Controlling Dengue: Immunization Is a Pillar of Prevention

443

Driving Earlier Detection of Liver Fibrosis Outside of the Hepatology Clinic

444

Syndromic Testing for Joint Infections: What Is It and Why Should It Matter to You?

445

Improving Outcomes and Quality of Life in Advanced GIST: Discussing the Patient Journey and the Latest Data

446

Cultural Competence: Leveling the Playing Field in Mental Health

447

Geographic Atrophy: Why, When and How to Treat

448

Hot Off the Press From AHA Scientific Sessions 2022: Key Data and Clinical Conversations on Cardiovascular Risk Reduction

449

News on NASH – Selected Highlights From the AASLD Liver Meeting 2022

450

When Antiretroviral Treatment Adherence Really Matters: Consequences and Communication for People Living With HIV

451

The Importance of Non-invasive Screening in NAFLD

452

Listen to Your Gut: The Gut-Brain Axis, Nutrition, and Infant Neurodevelopment

453

Concepts to Practice: The Evolving Landscape in Topical Therapies for Plaque Psoriasis

454

Medical Dermatology Potpourri II

455

New Strategies to Advance Care for Women: Broadening Horizons for Quality Care in Women's Health

456

Health Equity in Dermatology

457

TAAR1: A New Target With Therapeutic Potential for Psychiatric Conditions, Focus on Schizophrenia

458

Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Challenging Cases in the Clinic

459

Medical Dermatology Potpourri I

460

Case Review: Team-Based Approaches to Optimize Androgen Deprivation Therapy in Advanced Prostate Cancer

461

Confronting Racial and Ethnic Disparities in Cardioprevention: Actionable Insights to Enhance Patient Care

462

Module 2—Clinical Queries in Bipolar Depression: How Do You Provide Patient-Centered Care?

463

Biologics Targeting the IL-23/IL-17 Pathway in Psoriatic Disease: Treating Beyond the Skin

464

Lessons from the COVID Pandemic: Vaccines Are Essential Medicines Throughout the Life Course

465

Considering Health Equity in the Care of Patients With Alzheimer's Disease

466

Expert Perspectives on Improving Cardiovascular Disease Management in Women

467

Novel Once-Weekly Basal Insulins: Expert Interpretation of Latest Clinical Data

468

Does the Mechanism Matter? Breaking Down Novel Pharmacology in Bipolar Depression and Schizophrenia

469

Neurology Practice Updates

470

Migraine: A Review of Novel Therapeutics

471

Epilepsy: Expert Perspectives on Improving Outcomes

472

A Review of Rare Conditions Across the Lifespan: Pediatric Neuromuscular Disorders

473

Assessing Pruritus as Part of a Patient Visit for Dialysis

474

A Review of Rare Conditions Across the Lifespan: Adult Neuromuscular Disorders

475

Symptomatic Treatment of Sore Throat: Global Guidelines, Expert Perspectives and Best Practice

476

Ask the Expert: Focus on Frontline Treatment of Chronic Lymphocytic Leukemia

477

Optimizing Insomnia Management for the Elderly

478

Integrating Novel Strategies to Optimize Care of Patients With Chronic Graft vs Host Disease

479

European Society of Cardiology's Position on Renal Denervation: The Time Is Upon Us

480

Module 1: Clinical Queries in Bipolar Depression: What Tools Are Best for Screening and Diagnosis?

481

Key Considerations for the Topical Management of Psoriasis in Patients of Color

482

HIV Pearls for Primary Care: Recognizing and Managing Heavily Treatment-Experienced Patients With HIV

483

The Renal Denervation Durability Question Put to Rest

484

From Clinical Trials to Clinical Practice: Assessment of Insomnia Using Appropriate Scales

485

Optimizing Care of Patients With Chronic Lymphocytic Leukemia: Clinical Pearls for Nurses and Pharmacists

486

Abbreviated Liver MRI in Clinical Practice

487

PARP Inhibitor Combination Regimens for Prostate Cancer Management

488

Are We Ready for More BTK Inhibitors in Chronic Lymphoblastic Leukemia? Experts Discuss the Latest Data

489

Case Conversations in the Recognition and Management of Seizures in Tuberous Sclerosis Complex

490

Chronic Spontaneous Urticaria: Frequently Asked Questions

491

Comprehensive Management of a Patient on Dialysis With Pruritus

492

Pharmacologic Stress MRI for Assessment of Chest Pain Syndrome

493

Exploring HIV Management for HHS Recommendations: "Certain Clinical Situations"

494

Novel Treatment Options for CKD in Type 2 Diabetes – Evaluating Latest Landmark Trial Results

495

Supplemental Screening for Breast Cancer: Who, When, and How?

496

Respiratory Syncytial Virus Infection in Adults: Why It Should Be on Your Radar

497

How Important Is Sleep Architecture for Sleep Quality?

498

Prioritizing Pediatric Care for Managing Rare Tumors: Targeting NTRK Fusions as a Case Study

499

Countdown in Critical Care: Syndromic Testing for Bloodstream Infections

500

Rapid and Accurate Diagnosis in Meningitis & Encephalitis: Tips to Utilize Syndromic Testing in Practice

501

Demystifying the Role of Aspirin for Stroke Prevention

502

Current Evidence on the Use of Acetaminophen and NSAIDs for the Treatment of Osteoarthritis

503

Relationship Between Osteoarthritis, Inflammation, and Pain: A Closer Examination

504

Raising the Bar in HPV Screening - Power of Informed Prevention and Triage in Clinical Practice

505

Exploring Emerging Topical Treatments in Psoriasis: Are You Up to Date?

506

Roadmaps for Reducing High Blood Pressure

507

Latest Insights on Optimizing Outcomes in Chronic Thromboembolic Pulmonary Hypertension

508

Spotlight on Skin of Color in Dermatology

509

The Psoriasis Forum

510

Pediatric Pearls for Practice

511

Atopic Dermatitis Updates

512

Medical Dermatology Potpourri I

513

From the Plant to the Patient: Review of the Processes for Identifying and Producing Cannabidiol

514

Unfolding the Future of Alzheimer's Disease: What Primary Care Physicians Should Know

515

Where Are We With Real-Time Continuous Glucose Monitoring in Type 2 Diabetes?

516

Diagnosing and Managing Spasticity in Multiple Sclerosis: Team-Based Approach for Better Care

517

Pre-Exposure Prophylaxis for the Primary Care Provider

518

Digging Deep to Understand the Significance of Cytomegalovirus

519

Diagnostic Technologies: Elevating Antimicrobial Stewardship to the Next Level

520

Prostate Cancer Detection With MRI: Supporting Evidence and the Importance of Image Quality

521

Pulmonary Arterial Hypertension: Applying the Recommended Treatment Approaches

522

Time Matters in Alzheimer's Disease: A Patient Journey From Suspicion to Diagnosis

523

A Critical Review of Learnings From the '21 Clinical Trials on Alzheimer's Disease Conference

524

Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Context and Impact of New Data

525

State of the Art Care in Alzheimer's Disease: Exploring the Role of Biomarkers

526

A 360-Degree View of the Patient and Family Journey With Cytomegalovirus

527

Updates in Treating Newly Diagnosed Multiple Myeloma

528

A Better Option for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation

529

Manipulating the Disrupted Sleep-Wake Cycle in Insomnia

530

Maximizing the Heart Failure Pre-Discharge Toolkit: The Utility of Natriuretic Peptide Biomarker Assessment

531

Including the Patient Perspective in Pulmonary Arterial Hypertension Management

532

Over-the-Counter Analgesics/Antipyretics: Essential Medicines, Indispensable Medicines

533

Clinical Updates: Emerging Therapies for Patients With Multiple Myeloma

534

Improving Recognition of Heart Failure in Patients With Type 2 Diabetes: Prognostic Implications of Cardiac Biomarkers

535

Challenging Cases in Alzheimer's Disease: Applying Strategies to Inform Timely and Accurate Diagnosis

536

The Role of Biomarkers in HR-Positive/HER2-Negative Early Breast Cancer: From Clinical Analysis to Clinical Decisions

537

Optimizing the Management of Squamous Cell Carcinoma of the Head and Neck With Immunotherapeutic Strategies

538

Allergy Treatment: When Are Intranasal Corticosteroids and Antihistamines Appropriate?

539

Hot Topics in Over-the-Counter Options for Osteoarthritis: Topical vs Oral Analgesics

540

New Guidance on Managing Patients on Aspirin for Secondary Cardioprevention

541

Practical Insights for High-Risk Patients From the 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation

542

The Value of High-Sensitivity Cardiac Troponin Protocols for Optimal Patient Management: It's About Time

543

BCMA-Directed Therapy in Multiple Myeloma: Assessing the Clinical Impact

544

Optimizing Over-the-Counter Treatment of Nasal Congestion

545

Treatments for Bipolar Depression: Where We Are and Where We Are Going

546

OTC Analgesics/Antipyretics in a Post-Pandemic World: Rational Guidance for Improved Outcomes

547

Short Bowel Syndrome: Building Excellence in Care Across Your Multidisciplinary Teams

548

Insomnia in Practice: Understanding Causes and Consequences

549

From Evidence to Best Practices in Advanced GIST: Expert Analysis of the Latest Data

550

Advances in Pulmonary Artery Hypertension Care: Highlights From 2021 Congresses

551

Listening to Patient Preferences to Overcome Poor Adherence: Is This the Key to Better BP Control?

552

Caring for Patients With Advanced Basal Cell Carcinoma: Perspectives From the Interprofessional Team

553

What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update

554

Device-Based CV Care

555

Managing Atopic Dermatitis in Skin of Color: A Case-Based Discussion

556

Data Updates on the Use of On-Demand Therapies in Parkinson Disease

557

Digital Therapeutics and Devices in ADHD: Use in Clinical Settings

558

Ask Your Mentor: The Patient With Cognitive Symptoms

559

Best Practices in Narcolepsy: The Role of Dosing for Improving Outcomes With Sodium Oxybate

560

Advances in Digital Therapeutics and Devices in ADHD: A Review of the Evidence

561

Ask Your Mentor: MDD and Comorbid Conditions

562

PAH Management: Getting It Right Early to Optimize the Clinical Course

563

What Is on the Horizon for Managing Disease-Associated Growth Failure in Infants?

564

Precision Management of Migraine: A Guide to the Use of Preventive Therapies

565

Best Practices for the Myeloma Care Team: Optimizing Outcomes for Patients With R/R Multiple Myeloma

566

Safe and Effective Use of New Therapies for Diabetic Kidney Disease: Patient Selection Is Key

567

Exploring Novel Approaches With PI3K Inhibitors in R/R Follicular and Marginal Zone Lymphoma

568

Moving Beyond COVID-19: Syndromic Testing for Respiratory Tract Infections

569

2021-2022 Update: The Essential Guide for Nurses in HIV

570

Diagnosis and Management of Skeletal Dysplasias/Achondroplasia: Experts Weigh In

571

Syndromic Testing in the Era of COVID-19: A Strategic Approach to Pathogen Identification for Pneumonia

572

New Frontiers in Sustained Delivery: New Data and Surgical Advances for Age-Related Macular Degeneration and Diabetic Eye Disease

573

Putting the Patient at the Center of Major Depressive Disorder Care

574

Ask Your Mentor: MDD Treatment Modification

575

From Interpretation to Application: Syndromic Testing for Gastroenteritis

576

Reducing the Risk of Recurrence In HR+/HER2- Early Breast Cancer Requires Action: MDT Clinical Case Discussions

577

Defining the Core Role of Primary Care in the Early Recognition of Alzheimer's Disease

578

Ask Your Mentor: Depression Screening via Telemedicine

579

Through the Looking Glass: What Is the View on Eosinophilic Gastrointestinal Diseases?

580

Cases From the Clinic: A Perspective on Managing Schizophrenia in Community Practice

581

A 20/20 Perspective on Barrier Repair and Skin Care in Pediatric and Primary Care

582

The Science Behind the First COVID-19 Vaccines

583

Improving MRI Workflow: The Value of Abbreviated Protocols

584

The Nurse View on BTK Inhibitors: Optimizing Your Care of Patients with CLL

585

BTK Inhibitors in CLL: Summer Data Updates and Expert Perspectives

586

Communication Conundrums: Tips and Techniques for Addressing Questions About HPV Immunization

587

Clinical Pearls for Pharmacists: BTK Inhibitors for the Treatment of CLL

588

State of Care: A Closer Look at OAB in LTC Facilities

589

The Role of Retinoid Receptor Signaling in Acne Pathology, Pathophysiology, and Treatment

590

2021 Data Blitz From the American Headache Society Annual Scientific Meeting

591

Recent Updates on the Mutational and Treatment Landscape of Advanced GIST

592

SARS-CoV-2 Variants and Monoclonal Antibodies: What Do We Know?

593

Monoclonal Antibodies: Looking Beyond COVID-19

594

Out of Control: Perspectives on Worsening Trends in Blood Pressure Control Rates

595

Call to Action in the Hospital: Potassium Management in the Real World

596

Antibodies and Vaccines: Why We Still Need Post-Exposure Prophylaxis

597

Patient Questions and Expert Answers for Healthy Skin of Color

598

The Emerging Receptor Science in the Management of Schizophrenia

599

Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma

600

Barriers to Access and Connecting People to Care

601

Early Diagnosis of PAH: The Latest Tools and Approaches

602

Postexposure Prophylaxis for COVID-19 Prevention: Where Do We Stand?

603

Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy Considerations

604

Expert Perspective Series: Tips for Addressing Patients FAQs About COVID-19 Vaccines

605

Expanding Targetable Treatment in Thyroid Cancer: NTRK Fusions

606

Diagnostic Pearls in EGIDs Beyond EoE

607

Evidence Update and Practical Perspectives: Monoclonal Antibodies for COVID-19 Treatment

608

Vaccines vs Monoclonal Antibodies for COVID-19: Complementary Approaches to Tackling the Pandemic

609

Expert Exchange: The Why, When, and How of "On-Demand" Therapies for Parkinson Disease

610

Bipolar Depression: Putting the Patient at the Center of Care

611

Year in Review: Perspectives on JAK Inhibitors for Atopic Dermatitis

612

Mirror, Mirror on the Wall: The Perception of Acne

613

Ask the Experts: What Practical Information Do I Need to Know About Cannabinoids?

614

Everything You Need to Know About ICIs in Gynecologic Cancers

615

The Role of Antibiotic Stewardship in the Management of Rosacea

616

Challenges and Opportunities in the Use of Monoclonal Antibody Therapy for COVID-19

617

Emerging Treatments for Diabetic Macular Edema: New Data

618

Neutralizing the Virus: A Focus on SARS-CoV-2–Specific Monoclonal Antibodies

619

Gene Testing for Limb-Girdle Muscular Dystrophy: What, When, How

620

Optimizing Access to Monoclonal Antibodies for COVID-19: US Perspective

621

Understanding the Potential of Antibodies for COVID-19

622

New Horizons in Neovascular Age-Related Macular Degeneration: Latest Data and Expert Thoughts on Emerging Therapies

623

Fundamentals of Eosinophilic Gastrointestinal Diseases: What You Need to Know

624

Practical Management of Prostacyclin Pathway Therapy: A Focus on the Patient Experience

625

Potassium and Acid Regulation: Clinical Implications for Clinicians

626

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Vaccines

627

Expert Perspectives in Best Practices in Osteoarthritis Care

628

Essential Updates in GI Immunotherapy: HCC and Esophageal Cancers

629

Timing Is of the Essence for Migraine Prevention

630

rtCGM in Primary Care: Quick Tips for the Busy Clinician

631

Treatment Algorithms in Melanoma: Evaluating Where We Are and Where We Are Headed

632

Antiplatelet Therapy to Prevent Stroke: Where Does Aspirin Fit In?

633

Key Considerations for Managing Patients With Bipolar Disorder: What the PCP Needs to Know

634

Principles and Practicalities: The Logistics of Bringing NAbs Into Patient Care

635

Special Populations and Immune Checkpoint Inhibitors: Are They Safe?

636

A Clinician's Guide to Improve Early Detection and Treatment of Homozygous Familial Hypercholesterolemia (HoFH)

637

Updates and Advances: The Latest Data on Neutralizing the COVID-19 Pandemic

638

Updates in the Management of Treatment-Naive CLL

639

Depression Clinic: Can You Manage These Patients?

640

A Journey Into the Patient Experience of Frequent Migraine: Lessons for the Clinician

641

Expanding the Pharmacist's Role in rtCGM Use and Education in Practice

642

From Women/For Women: Perspectives in HIV Care

643

Personalizing Progressive Metastatic CRC Treatment

644

Choosing PAH Treatment With Short- and Long-Term Goals in Mind

645

Early Identification and Management of Infants With Growth Failure

646

Back to Basics With Cannabinoids: Endocannabinoids vs Phytocannabinoids

647

Updates in the Treatment of Multiply Relapsed/Refractory Multiple Myeloma

648

Assessing Current and Emerging Options for the Management of Peripheral T-Cell Lymphoma

649

Updates on Immune Modulators in Lung Cancer: Have We Met the Need?

650

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Treatment and Vaccines

651

Targeted Alpha Therapies in Prostate Cancer

652

Strategies for Ending the Pandemic: A Multipronged Approach

653

Shifting the Balance Between the Immune System and Cancer: Moving Beyond the PD-1/PD-L1 Axis

654

Best Practices for Assessing and Managing Side Effects of CLL

655

Involving Patients With Relapsed/Refractory Multiple Myeloma in Decision Making

656

Treatment Advances in NTRK Gene Fusion-Positive Sarcoma: What Do You Need to Know?

657

Updates in Atopic Dermatitis from the European Allergy Meeting

658

Stories From the Field: Rapid Diagnostic Testing for Meningitis in the ED

659

On the Frontlines: Testing for SARS-CoV-2

660

Expert Perspectives on the Management of Advanced Thyroid Cancer: What's New?

661

New Treatment Options for High-Risk COVID-19 Patients With Mild to Moderate Disease

662

Treatment of Major Depressive Disorder: A Foundational Perspective

663

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Testing for SARS-CoV-2

664

Stories From the Field: Updates on Syndromic Testing for RTIs and COVID-19

665

Prostate Cancer: A PSA on nmCRPC Updates

666

Challenging Cases in NAFLD and NASH: Diagnosis

667

Case Studies in Children With Hemophilia A: Leveraging PK for Use With SHL FVIII Replacement Therapy

668

Foundations for Measurement-Based Care for MDD

669

Patient Selection for Aspirin Therapy: Implications for Primary Care

670

Case Discussions in the Early Recognition of Duchenne Muscular Dystrophy (DMD)

671

Compass to Topical Antioxidants in Cosmeceuticals: Why, What, When, and How?

672

Putting it Into (Best) Practice: Diagnostic Challenges and Opportunities in Pneumonia

673

360-Degree Management of CKD Patients to Delay/Prevent Progression to ESRD

674

Stories From the Field: Syndromic Testing for Meningitis/Encephalitis

675

Pathways to Prevention: Optimizing Influenza Vaccination in the Era of COVID-19

676

Stories from the Field: Syndromic Testing for Respiratory Tract Infections in the COVID Era

677

Diet, Loop Diuretics, and/or Potassium Binders to Manage Hyperkalemia?

678

Views on the Flu: Maximizing Vaccination Opportunities in the COVID-19 Era

679

Optimizing the Management of Therapy-Related Adverse Events Across the Continuum of Care in GIST

680

Mission Critical: Improving the Timeliness and Accuracy of SMA Diagnosis and Management

681

OTC Cough and Cold Medicines: Ensuring Effectiveness for the Appropriate Patients

682

Over-the-Counter Treatments for Primary Dysmenorrhea

683

Personalizing Aspirin Treatment for Primary Prevention: Evaluating the Latest Evidence on Coronary Artery Calcium

684

Making the Diagnosis: Addressing the Challenge of Polymicrobial Infections in Acute Gastroenteritis

685

The ADHD Care Transition from Adolescence to Adulthood: Tips for Lifelong Management

686

Guideline-Directed Therapy for Heart Failure: Challenges and Solutions

687

Episode 3: Addressing Common Challenges in Anticoagulation in Atrial Fibrillation

688

Immunotherapy and the COVID-19 Pandemic: Addressing Clinical Case Challenges in Lung Cancer

689

Changing Paradigms in the Management of Advanced GIST Implications and Application of New Strategies

690

Cardioprevention and Diabetes: Assessing the Role of Aspirin and Antiplatelets

691

New Data on Schizophrenia in 2020: A QuickFire Exchange Between Experts

692

Acne Journal Club: What's New in Disease Pathophysiology

693

Stories from the Field: Rapid Diagnostics for Meningitis and Encephalitis

694

The GI Tract and COVID-19: How to Cut Risks and Keep Control

695

Practical Pain Management for School Nursing Staff

696

Episode 2: Atrial Fibrillation and NOACs: Are They All the Same?

697

COVID-19: Vulnerable Populations: Expert Perspectives and Practical Considerations From the United States

698

Management of NASH: What Do the Data Tell Us So Far?

699

COVID-19: Situation Update, Practice Essentials, and Answers From European Experts

700

The Burden of Acne: Scarring of the Face and Trunk

701

Episode 1: Stroke Prevention in Atrial Fibrillation: Why Are Patients Undertreated?

702

Stories From the Field: Rapid Diagnostics for RTIs

703

Targeting the Virus: Advancing the Treatment for COVID-19

704

Moving to Specialist Care in Migraine: Improving the Use of Migraine Prevention

705

The Face of Sleepiness in OSA: Understanding the Patient Experience

706

Rosacea Journal Club: What's New in Disease Pathophysiology

707

The HIV Prevention Toolbox: Priorities for Patients and Providers

708

Expert Perspectives on Seizure Rescue Therapies: What's New and Why It Matters

709

Putting GI Risk in Perspective: How Safe Are OTC Analgesics?

710

A Quick Reference Guide to the Therapeutic Use of Cannabinoids in Epilepsy

711

Psoriasis Cases and Concepts: What Is Clear?

712

The Healthcare Provider's Role in Hyperkalemia Management

713

The Impact of COVID-19 on Your Oncology Clinic: Navigating Cancer Care in a New World

714

Cardiometabolic Considerations in Narcolepsy

715

Case Conversations and Expert Perspectives in the Use of Anti-CGRP Antibody Therapies in Migraine

716

Hospital-Based Care of Pain: The Role of NSAIDs in the Emergency Department and Urgent Care

717

Stroke Prevention in Atrial Fibrillation: Latest Guidelines and Recommendations

718

PrEP 1-2-3: A Step-by-Step Guide to Incorporating PrEP Into Practice

719

The Aesthetic Gameshow: How Would you Approach These Patients?

720

Virtual Grand Rounds: Hyperkalemia, CKD,and Resistant Hypertension

721

Factor Xa Inhibitors in CAD/PAD: Where Are We Today?

722

What the PCP Needs to Know About Bipolar Depression

723

Emerging Clinical Data in Heart Failure: What's the Latest?

724

New HFrEF Therapies in the Spotlight: A Countdown to Clinical Knowledge

725

COVID-19 Pandemic: Implications & Coping Strategies for the Patient With Obesity

726

Rediscovering the Clinical Benefits of Aspirin: Arriving at New Conclusions

727

Risk-Assessment and Treatment of Pulmonary Embolism

728

Examining the Role of Real-Time CGM in Pregnancy

729

New Paradigms in PAD: Guidelines and Recommendations

730

Hyperkalemia From In-Hospital to Hospital Discharge: How Big a Problem Is It?

731

Improving Management of Dyslipidemia: Making the Most of the Care Team

732

The Latest Advances in HFrEF: New Data From ACC 2020

733

Clinical Consult: Hyperkalemia in Patients With T2D and CKD

734

Factor Xa Inhibitors in PAD: Assessing the Latest Data

735

Screening for Elevated Potassium: Who, What, and When?

736

Step-By-Step Guide to RAAS Inhibitor Optimization in Eligible Patients

737

Nursing Pearls for Clinical Care of Patients on BTK Inhibitors

738

Treatment Considerations for Managing Pediatric Bipolar Depression: The Experts Weigh In

739

Expert Recommendations for Treating CLL With BTK Inhibitors

740

Updates for Pharmacists: Utilizing BTK Inhibitors for the Treatment of CLL

741

Schizophrenia Journal Club: What Does the New Research Show?

742

Appropriate Treatment of Atrial Fibrillation: Which Dose for Which Patient?

743

Patient Assessment and Diagnosis of Peripheral Artery Disease

744

Mineralocorticoid Receptor Blockade and CVD: What's the Story?

745

Cancer-Associated Thrombosis and the Role of NOACs

746

Optimizing Prophylaxis: Case Studies in Incorporating PK Data to Improve Patient Care

747

New Data, New Opportunities in Treating Patients With Schizophrenia

748

Updates in CLL: Data and Recommendations for Using BTK Inhibitors

749

The Evolving Science of Novel Targets in HFrEF: What Every Healthcare Professional Needs to Know

750

Improving COPD Outcomes: Ensuring Success With Nebulized Therapy

751

NASH 101: What You Need to Know Now

752

Psoriasis and Metabolic Syndrome: What Is the Relationship?

753

Mineralocorticoid Receptor Antagonists: Are They All Created Equal?

754

CKD in T2D: Earlier Patient Identification for Improved Outcomes

755

Digging Deep in CKD in T2D

756

Extended Treatment for Venous Thromboembolism: Making the Right Choice

757

Countdown to Clinical Knowledge in Psoriatic Arthritis

758

Factor Xa Inhibitors in Coronary Artery Disease: Data, Guidelines, and Implications for Clinical Care

759

The Latest in PAD: Guidelines, Data, and Expert Interpretation

760

What's New in NOACs in AF? Evaluating Emerging Evidence

761

Treating Pulmonary Embolism Today: What Do the New Guidelines Say?

762

Atrial Fibrillation in Patients With Renal Impairment: How to Manage

763

Psoriatic Arthritis: Pathogenesis and Novel Targeted Therapies

764

Aspirin in 2019: What Every Physician Needs to Know